药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Sertaconazole
Fenquizone
Fenquizone may increase the excretion rate of Rivaroxaban which could result in a lower serum level and potentially a reduction in efficacy.
Sertaconazole
Clofenamide
Clofenamide may increase the excretion rate of Rivaroxaban which could result in a lower serum level and potentially a reduction in efficacy.
Sertaconazole
Clorexolone
Clorexolone may increase the excretion rate of Rivaroxaban which could result in a lower serum level and potentially a reduction in efficacy.
Sertaconazole
Cyclopenthiazide
Cyclopenthiazide may increase the excretion rate of Rivaroxaban which could result in a lower serum level and potentially a reduction in efficacy.
Sertaconazole
Mebutizide
Mebutizide may increase the excretion rate of Rivaroxaban which could result in a lower serum level and potentially a reduction in efficacy.
Sertaconazole
Mefruside
Mefruside may increase the excretion rate of Rivaroxaban which could result in a lower serum level and potentially a reduction in efficacy.
Sertaconazole
Meticrane
Meticrane may increase the excretion rate of Rivaroxaban which could result in a lower serum level and potentially a reduction in efficacy.
Sertaconazole
Cicletanine
Cicletanine may increase the excretion rate of Rivaroxaban which could result in a lower serum level and potentially a reduction in efficacy.
Sertaconazole
Spiradoline
Spiradoline may increase the excretion rate of Rivaroxaban which could result in a lower serum level and potentially a reduction in efficacy.
Sertaconazole
Rolofylline
Rolofylline may increase the excretion rate of Rivaroxaban which could result in a lower serum level and potentially a reduction in efficacy.
Sertaconazole
Canrenone
Canrenone may increase the excretion rate of Rivaroxaban which could result in a lower serum level and potentially a reduction in efficacy.
Sertaconazole
Canrenoic acid
Canrenoic acid may increase the excretion rate of Rivaroxaban which could result in a lower serum level and potentially a reduction in efficacy.
Sertaconazole
Azosemide
Azosemide may increase the excretion rate of Rivaroxaban which could result in a lower serum level and potentially a reduction in efficacy.
Sertaconazole
Ularitide
Ularitide may increase the excretion rate of Rivaroxaban which could result in a lower serum level and potentially a reduction in efficacy.
Sertaconazole
Tienilic acid
Tienilic acid may increase the excretion rate of Rivaroxaban which could result in a lower serum level and potentially a reduction in efficacy.
Sertaconazole
Piretanide
Piretanide may increase the excretion rate of Rivaroxaban which could result in a lower serum level and potentially a reduction in efficacy.
Sertaconazole
Theobromine
Theobromine may increase the excretion rate of Rivaroxaban which could result in a lower serum level and potentially a reduction in efficacy.
Sertaconazole
Quinethazone
Quinethazone may increase the excretion rate of Rivaroxaban which could result in a lower serum level and potentially a reduction in efficacy.
Sertaconazole
Mersalyl
Rivaroxaban may increase the excretion rate of Mersalyl which could result in a lower serum level and potentially a reduction in efficacy.
Sertaconazole
Lithium carbonate
Rivaroxaban may decrease the excretion rate of Lithium carbonate which could result in a higher serum level.